Purchase Order HT001425PE034
- Not listed
- This federal contract award was issued by the Defense Health Agency to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the provision of fish probes and other molecular assay reagents. The single-award Blanket Purchase Agreement (BPA) call has a ceiling value of $150,000.00 and a completion date of November 1, 2019. The contract is a firm fixed-price arrangement with no set-aside designation, reflecting Abbott Molecular's status as a large, established medical technology...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the supply of FISH probes. The award has a potential value of $150,000.00 and a completion date of October 31, 2020. Abbott Molecular is a for-profit manufacturer that provides molecular diagnostic products and services to federal government customers, including the Department of Veterans Affairs, Centers for Disease Control...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide fluorescence in situ hybridization (FISH) probes for the Joint Pathology Center. The contract, with a potential value of $150,000.00, is a firm-fixed-price arrangement with a completion date of January 7, 2022. Abbott Molecular is a for-profit organization that manufactures medical diagnostic products, including tests and systems used for disease...
- This federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, is for the purchase of VYSIS LSI IGH/BCL2 DUAL COLOR FUSION products. The $29,540.40 firm fixed-price purchase order was awarded by the Defense Health Agency, a component of the U.S. Department of Defense. The contract does not have a set-aside designation and is scheduled for completion on July 25, 2016. Abbott Molecular is a manufacturer of molecular diagnostic products and services that has received...
- The U.S. Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Abbott Molecular Inc., a manufacturer of molecular diagnostics equipment and testing services. The $340,000.00 contract is for the provision of reagents and peripheral consumable supplies such as magnesium chloride, HER-2 DNA probe kits, and control slides. The contract does not have a set-aside designation. Abbott Molecular, a subsidiary of Abbott Laboratories, has provided a range of molecular...
- The Defense Health Agency has awarded Abbott Molecular Inc. a firm fixed-price purchase order valued at $112,560 for full maintenance services on a government-owned Abbott m2000sp/rt diagnostic system located at the Diagnostic Countermeasures Branch of the Walter Reed Army Institute of Research in Silver Spring, Maryland. The contract, awarded on September 30, 2024, includes preventative maintenance, emergency repair, and technical support services and will remain in effect through September 29,...
- This federal contract award, with a ceiling value of $150,000.00, was issued by the Defense Health Agency (DHA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The award is for the delivery of FISH probes to support clinical diagnoses in the molecular laboratory at the Joint Pathology Center. The contract is a Blanket Purchase Agreement (BPA) Call, with a Firm Fixed Price pricing type, and an ultimate completion date of July 31, 2025. The contract does not have a set-aside...
- Abbott Molecular Inc. was awarded a $59,486.40 firm fixed price purchase order by the Department of the Air Force Air Education and Training Command to deliver a CF IVD kit with no set-aside designation. As a subsidiary of Abbott Laboratories, Abbott Molecular provides molecular diagnostic products and services to federal agencies. This award falls under existing Abbott Molecular contracts and blanket purchase agreements with various government customers to supply clinical testing platforms,...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price delivery order contract to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide M2000 TESTINGS. The contract, which has a potential value of $234,860.24, was not set aside for any specific business category. Abbott Molecular, a manufacturer of molecular diagnostic products and services, will perform the contract in Philadelphia, PA. This award is part of the Critical Analyzers,...
- The U.S. Department of Veterans Affairs (VA) has awarded a $159,750.00 firm-fixed-price purchase order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide Alinity M analyzer equipment. This contract has a period of performance through February 12, 2028 and is not designated as a set-aside contract. Abbott Molecular is a healthcare company that develops diagnostic products and services, including molecular diagnostics equipment, reagents, and testing services for federal...
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded a $140,638.18 firm fixed-price purchase order by the Defense Health Agency to supply specialized fish probes compatible with existing diagnostic equipment utilized by the molecular laboratory. The contract, awarded on September 30, 2025, carries an ultimate completion date of September 29, 2026, and will be performed in Silver Spring, Maryland. No set-aside designation was utilized for this award. Abbott Molecular, a leading provider of molecular diagnostic products and services, brings substantial expertise in supplying advanced testing solutions and specialized diagnostic reagents to federal healthcare systems. The Defense Health Agency, which supports the military's medical capabilities, frequently procures specialized diagnostic equipment and reagents to maintain operational readiness and clinical testing infrastructure across the Department of Defense. Abbott Molecular has established itself as a critical supplier to federal agencies including the Department of Veterans Affairs, Centers for Disease Control and Prevention, and Department of the Army, with a strong track record of delivering molecular diagnostic equipment, reagents, and testing services. This purchase order for fish probes—molecular biology tools used in fluorescence in-situ hybridization diagnostic procedures—represents a targeted procurement to enhance the agency's existing laboratory capabilities without requiring new equipment acquisition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $140.6k | 9/16/25 |